December 14, 2017 7:11pm
What about past shareholders; don’t they deserve to know where $30 M in three years went..?
After all employee lay-offs, de-listing determination and auction of corporate equipment and according to former employees and in my opinion, this is the same team that blew $30 M and never accounted for their spending, missed clinical results and questions of the CEO and CFO ignored female employee harassment issues within the executive staff.
Biostage Announces Binding Agreement for $4 Million Private Placement. To view this release online visit: http://ir.biostage.com/2017-12-14-Biostage-Announces-Binding-Agreement-For-4-0-Million-Private-Placement
There are currently 39 M shares outstanding with a float of 35.1 M shares …
Should whatever investors are left TRUST this team to manage the opportunity forward?
My opinion is … the SEC should be … INVOLVED and don’t forget the terminal suit hanging over its head like a “Sword of Damocles”!!
Can shareholders trust them as they just continue to pay themselves for their mismanagement of past opportunities?
Where is the SEC? There is more to come out …
The CEO and CFO should ... KNOW when to RESIGN and this BOD should be investigated for their LACK of fiduciary respnsibility!
